Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Accredo Health

Accredo Health, Incorporated ("Accredo") is a Memphis-based parent organization for a family of companies providing specialized contract pharmacy and related services beneficial to patients with certain costly, chronic diseases. Through its affiliated companies, Hemophilia Health Services, Inc., Nova Factor, Inc., and Sunrise Health Management, Inc., Accredo has designed its specialty services to focus primarily on bio-pharmaceuticals that:

are used on a recurring basis to treat chronic and potentially life threatening diseases;

are expensive, with an annual therapy cost as high as $200,000 per patient; and

require temperature control or other specialized handling as part of their distribution process.

Licensed as retail pharmacies, Accredo's subsidiaries ship most of their medications, overnight, in a refrigerated, confidential container, mainly to patients' homes or physicians' offices, where these medications are reconstituted and injected.



Currently, Accredo provides services that address the needs of patients with the following diseases; growth hormone deficiency, a pituitary disorder that causes short stature; Gaucher Disease, a hereditary liver enzyme deficiency; hemophilia, a hereditary bleeding disorder; multiple sclerosis, a debilitating disease of the central nervous system; Crohn's Disease, a chronic inflammatory disease affecting the gastrointestinal tract; respiratory syncytial virus (RSV), a respiratory infection common among high risk infants; rheumatoid arthritis, a chronic disease characterized by inflammation and destruction of the joints; immune deficiencies, a diverse group of disorders affecting the immune system; and, pulmonary arterial hypertension, a life threatening disorder that can severely compromise the function of the lungs and heart.



Accredo's companies have created customized patient support systems to provide a host of services for patients with these specific diseases. Click on either Hemophilia Health Services or Nova Factor on the above organization chart for more detail of specific services that are available.


Contact Details:
1640 Century Parkway
Memphis
TN
38134
United States of America
Tel:901.381.7442
Fax:901.385.3689
Email:kfinney@accredohealth.com
WWW:

www.accredohealth.com/




Loading...

Press Releases on Accredo Health:

BioPortfolio Logo
Study Finds Life-Threatening Risks from Medication Errors in Hospitals Treating Pulmonary Hypertension Patients 4th November, 2009 Medco Health Solutions, Inc.
SAN DIEGO, Nov. 4 /PRNewswire-FirstCall/ -- Pulmonary arterial hypertension (PAH) patients using infused drugs have suffered serious injury or in some cases died from medication errors in hospitals
Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 3rd November, 2009 Medco Health Solutions, Inc.
-- Cash balance at quarter-end of $2.0 billion, after paying down $400 million of short-term debt September Year-to-Date 2009 Highlights: -- Record adjusted prescription volume of
Accredo Renews Commitment to Memphis 22nd October, 2009 Medco Health Solutions, Inc.
MEMPHIS, Tenn., Oct. 22 /PRNewswire-FirstCall/ -- Accredo Health Group Inc. announced a 10-year renewal of its 240,000-square-foot headquarters at Century Center, positioning the nation's largest
Study Links Rheumatoid Arthritis Drug Adherence to Improved Medical Outcomes and Lower Costs 19th October, 2009 Medco
PHILADELPHIA, Oct. 19 /PRNewswire-FirstCall/ -- Rheumatoid arthritis (RA) patients who regularly adhere to their prescription drug regimen have fewer emergency room and doctor visits and incur lower
Medco Announces Date for Second-Quarter 2009 Financial Results 30th June, 2009 Medco Health Solutions, Inc.
FRANKLIN LAKES, N.J., June 30 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) plans to announce its second-quarter 2009 financial results in a press release before the market opens

BioNews Results for Accredo Health:

Study Finds Life-Threatening Risks from Medication Errors in Hospitals Treating Pulmonary Hypertension Patient
Pharma Live:  Nov 6 2009 7:51AM Matching: accredo health
PAH patients face life-threatening risks from medication errors
News-Medical.Net:  Nov 4 2009 1:46PM Matching: accredo health
Study Finds Life-Threatening Risks from Medication Errors in Hospitals Treating Pulmonary Hypertension Patient
Therapeutics Daily:  Nov 4 2009 1:19PM Matching: accredo health
Study Finds Life-Threatening Risks from Medication Errors in Hospitals Treating Pulmonary Hypertension Patients Study reveals wrong dose and other dr
Yahoo! Canada:  Nov 4 2009 1:18PM Matching: accredo health
Medco Health 3Q profit jumps 13.5 percent
Pharmacy Choice:  Nov 3 2009 8:53PM Matching: accredo health
Promote your company here: BioNewsCast - Press Release Distribution

View more Accredo Health news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1372 times since April 2007, the link to the organisation's website has been followed 168 times

Recent Search Terms used to find this page: ACCREDO NOVEMBER 2009 | accredo health canada | Accredo | email contacts at Accredo Health | accredo 2009 | Accredo address | Accredo address | ACCREDO LOCATIONS | find email addresses for Accredo Health employees | Accredo MEDCO Health Solutions | .

Search for more companies in Memphis

Search for more companies in TN



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Accredo Health

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.